New neurotrophic keratitis drug closer to EU approval


The European Medicines Agency s Committee for Medicinal Products for Human Use (CHMP) is recommending the approval of cenegermin (Oxervate) for the treatment of moderate or severe neurotrophic keratitis in adults.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/new-neurotrophic-keratitis-drug-closer-to-eu-approval/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s